Amneal Pharmaceuticals Inc. (2DT)
FSX
Real-time Data
06:00 AM
Day's Range
14.7052 wk Range
7.75Overview - 2DT - Amneal Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
6.42B
P/E (Trailing)
‪36.34‬
P/E (Forward)
‪16.37‬
PEG Ratio
‪0.23‬
Price / Sales (TTM)
‪1.66‬
Price / Book
‪169.04‬
EV / EBITDA
‪10.88‬
Profitability
Gross Margin
‪42.01%‬
Profit Margin
‪5.04%‬
Operating Margin
‪18.33%‬
Return on Assets
‪8.59%‬
Return on Equity
‪613.01%‬
Ownership
Shares Outstanding
319.33M
Float
186.05M
Held by Insiders
‪52.16%‬
Held by Institutions
‪48.41%‬
Price stats
Beta
‪1.25‬
50-Day Avg
‪14.70‬
200-Day Avg
‪11.79‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 2DT - Amneal Pharmaceuticals Inc.
Peers - 2DT - Amneal Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- 2DTFSXAmneal Pharmaceuticals Inc.5.22BMarket Cap+49.67%52-week change35.71P/E (Trailing)‪5.04%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation107.87BMarket Cap+24.53%52-week change35.09P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA59.69BMarket Cap+19.31%52-week change23.51P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR59.12BMarket Cap+20.59%52-week change23.25P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG42.44BMarket Cap+22.10%52-week change58.15P/E (Trailing)‪14.57%‬Profit Margin
- H6D0FSXHaleon plc37.06BMarket Cap+1.29%52-week change20.06P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - 2DT - Amneal Pharmaceuticals Inc.
About
Amneal Pharmaceuticals Inc. is a global biopharmaceutical company that develops, manufactures, and distributes a diverse portfolio of essential medicines across three reportable segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers a broad range of generic pharmaceuticals in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
